Retour
Fourchette du Jour
176,36 €
182,16 €
Fourchette 52 Semaines
122,00 €
208,31 €
Volume
1 442 477
Moyenne 50J / 200J
176,25 €
/
159,78 €
Clôture Précédente
173,18 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 31,6 | 0,4 |
| P/B | 3,2 | 2,9 |
| ROE % | 10,4 | 3,8 |
| Net Margin % | 10,2 | 3,9 |
| Rev Growth 5Y % | 0,5 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
197,30 €
+9.1%
Low: 140,00 €
High: 220,00 €
P/E Prévisionnel
16,0
BPA Prévisionnel
11,31 €
Croissance BPA (est.)
+0,0%
CA Est.
4,2 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2029 |
15,71 €
15,49 € – 16,21 €
|
4,9 B | 2 |
| FY2028 |
13,51 €
12,97 € – 14,73 €
|
4,6 B | 4 |
| FY2027 |
12,30 €
11,79 € – 12,60 €
|
4,4 B | 10 |
Points Clés
Revenue grew 0,52% annually over 5 years — modest growth
ROE of 10,39% — decent returns on equity
Debt/Equity of 0,03 — conservative balance sheet
Generating 490,78M in free cash flow
P/E of 31,62 — premium valuation
Cash machine — converts 119,60% of earnings into free cash flow
Croissance
Revenue Growth (5Y)
0,52%
Revenue (1Y)0,90%
Earnings (1Y)-2,61%
FCF Growth (3Y)-10,16%
Qualité
Return on Equity
10,39%
ROIC11,10%
Net Margin10,17%
Op. Margin15,27%
Sécurité
Debt / Equity
0,03
Current Ratio1,36
Interest Coverage0,00
Valorisation
P/E Ratio
31,62
P/B Ratio3,20
EV/EBITDA19,49
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0,90% | Revenue Growth (3Y) | 2,21% |
| Earnings Growth (1Y) | -2,61% | Earnings Growth (3Y) | -3,98% |
| Revenue Growth (5Y) | 0,52% | Earnings Growth (5Y) | -14,61% |
| Profitability | |||
| Revenue (TTM) | 4,03B | Net Income (TTM) | 410,35M |
| ROE | 10,39% | ROA | 6,58% |
| Gross Margin | 68,33% | Operating Margin | 15,27% |
| Net Margin | 10,17% | Free Cash Flow (TTM) | 490,78M |
| ROIC | 11,10% | FCF Growth (3Y) | -10,16% |
| Safety | |||
| Debt / Equity | 0,03 | Current Ratio | 1,36 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 31,62 | P/B Ratio | 3,20 |
| P/S Ratio | 3,22 | PEG Ratio | 51,80 |
| EV/EBITDA | 19,49 | Dividend Yield | 0,00% |
| Market Cap | 12,98B | Enterprise Value | 12,01B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4,03B | 4,00B | 3,86B | 3,73B | 3,95B |
| Net Income | 410,35M | 421,36M | 445,05M | 361,57M | 772,02M |
| EPS (Diluted) | 5,65 | 5,62 | 5,81 | 4,61 | 9,69 |
| Gross Profit | 2,76B | 2,80B | 2,71B | 2,63B | 2,94B |
| Operating Income | 616,22M | 607,63M | 643,34M | 642,60M | 976,40M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 6,23B | 6,21B | 6,08B | 5,95B | 5,94B |
| Total Liabilities | 2,18B | 2,36B | 2,45B | 2,35B | 2,32B |
| Shareholders' Equity | 4,05B | 3,85B | 3,63B | 3,60B | 3,62B |
| Total Debt | 114,45M | 119,28M | 126,62M | 126,91M | 125,38M |
| Cash & Equivalents | 1,08B | 1,04B | 937,44M | 942,05M | 1,10B |
| Current Assets | 2,62B | 2,49B | 2,45B | 2,42B | 2,49B |
| Current Liabilities | 1,92B | 2,04B | 2,07B | 1,93B | 1,92B |